Clinical trials of anti-vascular agent group B Streptococcus toxin (CM101)
Angiogenesis
.
1997;1(1):36-7.
doi: 10.1023/A:1018353015650.
Author
A L Harris
1
Affiliation
1
Medical Oncology Unit and Molecular Oncology Laboratory, Imperial Cancer Research Fund, Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.
PMID:
14517391
DOI:
10.1023/A:1018353015650
No abstract available